Pages that link to "Q46969260"
Jump to navigation
Jump to search
The following pages link to Effect of aging on the expression of peroxisome proliferator-activated receptor gamma and the possible relation to insulin resistance (Q46969260):
Displaying 16 items.
- The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury (Q33561725) (← links)
- Peroxisome proliferator-activated receptor γ: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosis (Q35954579) (← links)
- Fibrosis in systemic sclerosis: common and unique pathobiology (Q36012572) (← links)
- Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy (Q36323842) (← links)
- Long noncoding RNAs in diseases of aging (Q36422024) (← links)
- Fibrosis in systemic sclerosis: Emerging concepts and implications for targeted therapy (Q37721063) (← links)
- Peroxisome proliferator-activated receptor gamma interacts with CIITA x RFX5 complex to repress type I collagen gene expression. (Q40111521) (← links)
- Resistance training regulates gene expression of molecules associated with intramyocellular lipids, glucose signaling and fiber size in old rats (Q41446819) (← links)
- Metabolomics of the interaction between PPAR-alpha and age in the PPAR-alpha-null mouse (Q43125313) (← links)
- Long non-coding RNAs in aging organs and tissues (Q48295735) (← links)
- Aging-Associated Changes in Physical Performance and Energy Metabolism in the Senescence-Accelerated Mouse (Q48890486) (← links)
- An aPPARent Functional Consequence in Skeletal Muscle Physiology via Peroxisome Proliferator-Activated Receptors. (Q53684513) (← links)
- Adipose Lipocalin 2 overexpression protects against age-related decline in thermogenic function of adipose tissue and metabolic deterioration (Q64278207) (← links)
- Involvement of adiponectin in age-related increases in tear production in mice (Q90609961) (← links)
- The role of PPARγ in childhood obesity-induced fractures (Q91671899) (← links)
- Pioglitazone Reduces β Amyloid Levels via Inhibition of PPARγ Phosphorylation in a Neuronal Model of Alzheimer's Disease (Q92403082) (← links)